Abstract
Background Coronary Artery Bypass Graft (CABG) surgery is a high-risk surgery (mortality rate between 2-4 percent) performed in patients with ischemic heart disease (IHD). Cardiovascular diseases are strongly associated with comorbidities. This study aimed to assess the prediction of in-hospital mortality by comorbidities in patients who underwent single, double, triple, or quadruple and more CABG.
Methods The National Inpatient Sample (NIS) database was used to extract patients who received 1, 2, 3, or 4+ CABG between the last quarter of 2015 and 2020. Best-fit model by logistic regressions was used to predict in-hospital mortality by Elixhauser Comorbidity Index (ECI). Moreover, age was adjusted in ECI prediction.
Results In-hospital mortality was best predicted by ECI in patients who underwent 3 CABG (c-statistic = 0.6325, 95% CI = 0.6151-0.6499), followed by 4+ CABG (c-statistic = 0.6308, 95% CI = 0.5997-0.6620), 1 CABG (c-statistic = 0.6194, 95% CI = 0.6108-0.6281), and 2 CABG (c-statistic = 0.6193, 95% CI = 0.6069-0.6317). After adjusting for age, ECI adequately predicted in-hospital mortality in 4+ CABG (c-statistic = 0.7196, 95% CI = 0.6916-0.7477) and 3 CABG (c-statistic = 0.6937, 95% CI = 0.6774-0.7101). The predictive power for age-adjusted ECI was comparable in 1 CABG (c-statistic = 0.6674, 95% CI = 0.6594-0.6755) and 2 CABG (c-statistic = 0.6664, 95% CI = 0.6549-0.6780).
Conclusions This study showed that ECI alone was a moderate (c-statistic 0.6-0.7) predictor of in-hospital mortality in all CABG. Age-adjusted ECI could effectively predict in-hospital mortality, especially in patients who underwent 3 and 4+ CABG.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of The George Washington University waived ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Method section updated.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Non-standard Abbreviations and Acronyms
- AUC
- area under curve
- CABG
- Coronary Artery Bypass Graft
- CI
- confidence interval
- ECI
- Elixhauser Comorbidity Index
- ICD-10-CM
- International Classification of Diseases, Tenth Revision, Clinical Modification
- ICD-10-PCS
- International Classification of Diseases, Tenth Revision, Procedure Coding System
- IHD
- ischemic heart disease
- NIS
- National (Nationwide) Inpatient Sample
- ROC
- receiver operating characteristic
